Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes
Open Access
- 1 May 2003
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (5) , 1439-1448
- https://doi.org/10.2337/diacare.26.5.1439
Abstract
— We examined whether plasma fibrinogen levels and the β-fibrinogen gene G−455→A polymorphism were related to microvascular or macrovascular disease in patients (n = 909) with type 1 diabetes enrolled in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC). Univariate regression showed that fibrinogen levels were correlated with BMI (r = 0.15; P < 0.0001), HbA1c (r = 0.11; P = 0.0014), total cholesterol (r = 0.17; P < 0.0001), and LDL cholesterol (r = 0.16; P < 0.0001) in all patients. In men, but not women, waist-to-hip ratio (r = 0.20; P < 0.0001) and triglycerides (r = 0.13; P = 0.0047) also became powerful predictors of fibrinogen level; in women, but not men, fibrinogen was correlated with both diastolic (r = 0.16; P = 0.0011) and systolic (r = 0.11; P = 0.0241) blood pressure. Fibrinogen was correlated with urinary albumin excretion rates in men (r = 0.13; P = 0.0033), but not in women. In both sexes, however, the development of proteinuria (albumin excretion >300 mg/24 h) was accompanied by 1.5-fold increment in plasma fibrinogen compared with patients with normal excretion or microalbuminuria. In addition, high fibrinogen levels were associated with a lower average ankle-brachial index in women (r = −0.13; P = 0.0075), but not men. Multiple regression analyses demonstrated that plasma fibrinogen was independently correlated with high albumin excretion rate in men, and with low average ankle-brachial index in women. Fibrinogen was not correlated with the severity of retinopathy. Carotid artery intima-medial thickness was not correlated with fibrinogen, and the G−455→A polymorphism in the 5′ promoter region of the β-fibrinogen gene did not influence circulating fibrinogen levels. However, the presence of the more common G−455 allele was associated with greater intima-medial thickness in the internal carotid artery (ANCOVA P = 0.045). Last, hyperfibrinogenemia in type 1 diabetes is associated with components of the insulin resistance syndrome trait cluster, and the association is influenced by sex.Keywords
This publication has 52 references indexed in Scilit:
- Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery StudyBlood Coagulation & Fibrinolysis, 2000
- Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study Edinburgh Artery StudyEuropean Heart Journal, 1999
- A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.Journal of Clinical Investigation, 1997
- Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and womenThe American Journal of Cardiology, 1996
- Plasma Fibrinogen in NIDDM: The Rotterdam StudyDiabetes Care, 1996
- European Atherosclerosis Research Study: Genotype at the Fibrinogen Locus (G −455 -A β-Gene) Is Associated With Differences in Plasma Fibrinogen Levels in Young Men and Women From Different Regions in EuropeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Hemostasis Variables in Type I Diabetic Patients Without Demonstrable Vascular ComplicationsDiabetes Care, 1993
- Prothrombotic and Antithrombotic Factors are Elevated in Patients with Type 1 Diabetes Complicated by MicroalbuminuriaDiabetic Medicine, 1993
- Haemostatic Measures in Type 2 Diabetic Patients with MicroalbuminuriaDiabetic Medicine, 1990
- A solid phase fluorescent immunoassay for the measurement of human urinary albuminKidney International, 1984